** Shares of medical device maker GE Healthcare Technologies GEHC.O rise 3% to $69.03
** China's government is considering suspending its 125% tariff on some U.S imports, including medical equipment and some industrial chemicals like ethane, according to a Bloomberg News report
** Brokerage J.P. Morgan says it will benefit players like GEHC since hospitals in China still rely on advanced medical equipment, including large capital like surgical robots, MRI and ultrasound machines, for which domestic competition is lagging
** GEHC has previously said it expects its full-year profit to be hit due to U.S. tariffs imposed on products from China
** The company's China sales declined 15% in 2024, and it expects sales in the region to remain under pressure in the near term
** Thirteen out of 19 brokerages rate the stock "buy" or higher, 5 rate "hold", 1 rate "sell" and their median PT is $96.36 as per data compiled by LSEG
** Including session moves, GEHC stock down 11.1% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。